Find Academic Supervisors

Vincent AluquinView profile

Associate Professor

• Pulmonary Hypertension
• Bronchopulmonary Dysplasia
• Sickle-Cell Disease
• +4 more

Vincent Aluquin, MD, MS serves as an Associate Professor in the Department of Pediatrics Children's Heart Group at Penn State College of Medicine. His clinical and research work focuses on pediatric cardiovascular conditions with particular expertise in pulmonary hypertension and related disorders in children. Dr. Aluquin's primary research interests center on pulmonary hypertension in pediatric populations, particularly as it relates to bronchopulmonary dysplasia in preterm infants, sickle cell disease complications, and inflammatory conditions. His work spans multiple disciplines including neonatology, cardiology, pulmonology, and hematology, with a strong emphasis on identifying biomarkers and developing diagnostic approaches for complex pediatric cardiovascular conditions. Analysis of Dr. Aluquin's publication record reveals a consistent research trajectory focused on understanding the pathophysiology of pulmonary hypertension in pediatric populations. His most recent work employs multiomics approaches to characterize disease subtypes, particularly in preterm infants with bronchopulmonary dysplasia. Earlier publications established important connections between nocturnal hypoxia and pulmonary hypertension in sickle cell disease, and explored cardiovascular complications in patients undergoing stem cell transplantation. Dr. Aluquin has collaborated extensively with researchers across multiple disciplines, including pulmonologists, immunologists, and hematologists. His work on folate receptor beta expression demonstrates cross-disciplinary collaboration with rheumatology researchers studying inflammatory conditions. Dr. Aluquin's research program appears to focus on the Children's Heart Group within the Department of Pediatrics, where he investigates cardiovascular complications in children with complex medical conditions. His work bridges clinical care and basic science research to improve outcomes for pediatric patients with cardiovascular disorders.

• Nutrition and Dietetics
• Sustainable Nutrition
• Maternal and Child Nutrition
• +3 more

Merve Şeyda Karacil Ermumcu is an Associate Professor at Akdeniz University's Faculty of Health Sciences, Department of Nutrition and Dietetics. She previously served as Assistant Professor at multiple Turkish universities (2020-2024). With a doctorate from Gazi University (2019) and postgraduate training in nutrition, her career spans academic roles, research projects, and significant publication output. Education : PhD in Nutrition and Dietetics (2019), MSc (2014), BSc (2011) from Turkish universities Positions : Academic roles at Akdeniz, Atilim, and Erzincan universities As a nutrition researcher, her work focuses on sustainable diet practices, maternal/child nutrition, and obesity-related dietary factors. She has explored Mediterranean diet adherence, water/carbon footprint of nutrition, and pandemic-era dietary changes through 118 WoS-indexed publications and 15 Scopus papers. Recent publications examine ecological nutrition awareness (2022-2024), dietary tool validation (2022), and pandemic impacts on supplement use (2021). Her research spans from clinical applications (pediatric inpatients) to population-level studies (elderly, college students). She serves as principal investigator for TUBITAK-funded projects on sarcopenia risk (2023-2024) and nutrition-hydration status in athletes (2022-2023). Her methodological expertise includes cross-sectional studies, validity testing, and life cycle assessments. Teaching responsibilities include courses on Sustainable Living and Nutrition, Functional Foods, and Nutritional Problems & Epidemiology. She has presented at 20+ international conferences since 2012, including European Congress on Obesity and ESPEN Congress.

Thomas HelledayView profile

Professor

• Chemical Biology
• DNA Damage Response
• Cancer Therapy
• +5 more

Thomas Helleday is a Professor of Chemical Biology at the Karolinska Institutet , affiliated with the Department of Oncology-Pathology and SciLifeLab. His research focuses on exploiting DNA damage response (DDR) and metabolic vulnerabilities in cancer cells. Education: Biologist, Professor at 34 Prior Affiliations: Stockholm University, University of Sheffield, University of Oxford Key research areas include catalytic medicine (e.g., amplizymes activating DNA repair proteins), synthetic lethality (PARP inhibitors for BRCA-mutant cancers), and metabolic reprogramming in tumors. His work has led to the development of karonudib (MTH1 inhibitor) and TH1579 (mitotic DDR inhibitor), with clinical trials ongoing. Recent publications highlight advancements in OGG1 inhibition for inflammation, MTHFD2 targeting in AML, and NUDIX hydrolase family exploration. His interdisciplinary lab integrates molecular biology , medicinal chemistry , and clinical translation . Scientific Awards: Wallenberg Scholar Key Collaborations: University of Sheffield, Novo Nordisk Foundation, European Research Council Students include Saeed Eshtad (2012 thesis) and Johan Boström (2014 thesis). Funding sources span Swedish Research Council , ERC , Swedish Cancer Society , and industry partnerships.

HATİCE TUBA AKBAYRAMView profile

Associate Professor

• Family Medicine
• Internal Medicine
• Primary Care
• +8 more

Associate Professor Hatice Tuba Akbayram is affiliated with Gaziantep University Faculty of Medicine , where she serves in both the Department of Internal Medicine and Department of Family Medicine . She holds a medical specialization in Family Medicine and has contributed extensively to research in Pediatric Hematology , Public Health , and Mental Health through 42 peer-reviewed articles and 3 book chapters. Education: Medical License (Selcuk University, 2001), Medical Specialization (Yuzuncu Il University, 2015), Health Sciences University (2013) Her research focuses on health behavior during pandemics , mental health in medical education , and diagnostic hematology in pediatric populations . Recent studies analyze erythrocyte indices in iron deficiency , herbal product use in diabetes , and psychological barriers in medical students . She supervises 15 medical specialization theses , including topics on post-traumatic stress in physicians , antibiotic use in preschool children , and mental health during pandemics . Her work appears in SCI-Expanded , SSCI , and TR DİZİN journals, with international conference participation in Eastern Mediterranean Family Medicine Congress and Wonca Europe Conference .

ELİF İŞBİLENView profile

Associate Professor

• Medical Biochemistry
• Vitamin D Research
• Infertility Studies
• +7 more

ELİF İŞBİLEN is an Associate Professor at Gaziantep University Faculty of Medicine, Department of Basic Medical Sciences, specializing in Medical Biochemistry. She has maintained continuous academic and clinical engagement since completing her medical education at Selçuk University and Istanbul University. Her educational background includes a medical degree from Selçuk University Meram Faculty of Medicine (1989-1994) followed by specialization in Basic Medical Sciences/Biochemistry at Istanbul University Faculty of Medicine (1999-2003). Dr. İşbilen's research focuses on the molecular mechanisms of reproductive disorders, particularly examining vitamin D metabolism, oxidative stress biomarkers, genetic polymorphisms, and circadian rhythm in conditions like infertility, preeclampsia, and ADHD. Her work integrates clinical biochemistry with molecular genetics to identify potential biomarkers and therapeutic targets. Her publication record demonstrates consistent research productivity over two decades, with recent work emphasizing vitamin D's role in cancer survival, reproductive health, and neurodevelopmental disorders. The research shows a clear trajectory from foundational work on preeclampsia and homocysteine metabolism toward contemporary investigations of circadian biology and non-coding RNA in disease pathogenesis. Scientific recognition includes: Dr. Cengiz Çetin thesis competition award Dr. İşbilen has supervised multiple graduate theses and secured research funding through national projects, including five Higher Education Council-supported projects where she served as principal investigator or researcher. Her teaching portfolio is extensive, covering biochemistry topics across multiple academic years in both Turkish and English.

Melissa G MitchumView profile

Professor

• Plant Nematology
• Molecular Plant-Pathogen Interactions
• Peptide Hormone Mimicry
• +5 more

Melissa G. Mitchum is a Professor of Plant Nematology at the University of Georgia , affiliated with the Department of Plant Pathology , Institute of Plant Breeding, Genetics & Genomics , and Center for Applied Genetic Technologies . Her research focuses on molecular plant-nematode interactions with emphasis on cyst and root-knot nematodes. Ph.D. in Plant Pathology (minor Biotechnology) - North Carolina State University (2001) Postdoctoral Fellow - Duke University (2003) MS in Plant Pathology - University of Nebraska (1995) BS in Biology - University of Puget Sound (1993) Research explores nematode effector proteins that manipulate plant developmental pathways through CLE peptide mimicry , phytohormone hijacking , and nuclear-targeted gene regulation . Key work includes identifying serine hydroxymethyltransferase 8 as a critical resistance gene and discovering nematode secreted receptor-interacting effectors . Current projects integrate CRISPR genome editing , transcriptomics , and high-throughput phenotyping to engineer nematode-resistant crops. Collaborates with plant breeders across North America to develop durable resistance strategies through gene pyramiding and rotation systems .

Mengmeng DuView profile

Associate Professor

• Epidemiology
• Cancer Research
• Endometrial Cancer
• +6 more

Mengmeng Du is an Associate Attending Epidemiologist at Memorial Sloan Kettering Cancer Center with a joint appointment as Associate Professor at Weill Cornell Medicine. Her primary affiliation is with the Epidemiology & Biostatistics department where she leads critical research initiatives focused on reducing cancer burden in underserved populations. Dr. Du's research spans endometrial, colorectal, and pancreatic cancers with particular emphasis on health disparities affecting Black women and international populations. She leads the Data Coordinating Center for the Epidemiology of Endometrial Cancer Consortium (E2C2) investigating the twofold higher endometrial cancer mortality in Black women, and directs the MSK Pancreatic Tumor Registry. Her work with the African Research Group for Oncology (ARGO) examines colorectal cancer genomics in Nigerian populations. Recent publications demonstrate her leadership in large-scale pooled analyses examining obesity trajectories, hypertension, and night shift work as risk factors for endometrial cancer, alongside innovative work on pancreatic cancer risk prediction models. Dr. Du is deeply committed to scientific education as co-director of MSK's Quantitative Sciences Undergraduate Research Experience (QSURE) program and serves on the MSK Research Council and NYC Epidemiology Forum Scientific Committee. Her research is funded by the National Cancer Institute, National Center for Advancing Translational Sciences, David M. Rubenstein Center for Pancreatic Cancer Research, and philanthropic sources.

• Orthopedic Surgery
• Trauma Surgery
• Gene Therapy
• +5 more

Dr. Julio Fernandez is a Full Professor in the Department of Surgery at the University of Montreal's Faculty of Medicine and holds the Research Chair in Orthopedics at the Sacré-Coeur Hospital of Montreal. With over CAD 13 million in research funding secured over 20 years and international collaborations spanning Canada, China, and Brazil, he ranks among the youngest full professors in his department while maintaining an active global research presence. His academic credentials include: MD MSc Dr. Fernandez's research integrates orthopedic surgery with cutting-edge biomaterials science, focusing on non-viral gene therapy using polymeric nanoparticles, surgical instrumentation, bone quality analysis via guided waves, osteoporosis management, fracture care, and blood conservation in joint replacement. His work addresses critical challenges in trauma response and long-term musculoskeletal health through translational approaches. His publication record reveals a clear evolution from foundational biomaterials development (notably chitosan-DNA nanoparticles for gene delivery) toward clinical applications in bone health and trauma care, with recent work emphasizing cellular uptake mechanisms in non-viral gene therapy. This trajectory demonstrates consistent innovation bridging nanotechnology and orthopedic surgery. Key recognition includes: Research Chair in Orthopedics, University of Montreal Dr. Fernandez has secured over $700,000 in targeted research grants and mentored graduate students through international exchanges under Brazil's Science Without Borders program, reflecting his commitment to global academic development. His visiting professorships across ten countries underscore his international influence. His research operates within the Trauma – acute care axis at Sacré-Coeur Hospital, directing interdisciplinary teams that advance orthopedic innovation through polymeric nanoparticle development and bone health analytics.

• Cancer Epidemiology
• Colorectal Cancer Survivorship
• Exercise Intervention Trials
• +5 more

Cornelia Ulrich is Professor and Jon M & Karen Huntsman Presidential Professor in Cancer Research at the University of Utah , serving as Chief Scientific Officer and Executive Director of the Comprehensive Cancer Center at Huntsman Cancer Institute. She leads over 280 cancer research teams through her international ColoCare Study consortium. PhD, University of Washington MS, Oregon State University BS, University of Hohenheim Her research bridges cancer epidemiology , exercise interventions , and multi-omics biomarker discovery , with over 500 publications and $70M+ in grants. Key areas include: Colorectal cancer prevention and survivorship Physical activity's impact on inflammation and angiogenesis Microbiome-tumor interactions Diet-gene-environment interplay Cancer-related fatigue and distress Recent studies focus on kynurenine pathway metabolites , vitamin B6 , and weight loss effects on cancer outcomes. Awards include the Simon Shubitz Award and research.com Best Female Scientist .

• Epigenetic Epidemiology
• DNA Methylation
• Genomic Medicine
• +3 more

Dr. Rachelle Irwin is a Lecturer in Genomic Medicine and Principal Investigator at Ulster University's Centre for Genomic Medicine. She holds a BSc (First Class Hons) and PhD from Ulster University, where she studied maternal programming of neural gene methylation. Dr. Irwin teaches undergraduate/postgraduate courses and directs the BSc Biology program, which achieved Royal Society of Biology accreditation under her leadership. Her research focuses on epigenetic epidemiology , particularly DNA methylation's role in health and disease. Key interests include: Nutrient-epigenome interactions (folic acid/folate) Neural development and aging Methylome analysis techniques Clinical translation of epigenetic biomarkers Recent publications explore active learning pedagogies (2024), epigenetic effects of B vitamins (2023), and senescence signatures in COVID-19 (2024). Her work consistently demonstrates interdisciplinary integration of molecular biology with public health. Awards & Recognition: Irish Society of Human Genetics Best Talk (2017) Ulster Immunology Group Student Prize (2012) As a principal investigator, she leads the Centre for Genomic Medicine and supervises five PhD researchers. She secured research funding from BBSRC/ESRC and Northern Ireland Chest Heart and Stroke. Dr. Irwin maintains editorial roles at Frontiers in Genetics , Frontiers in Endocrinology , and the Journal of Childhood and Adolescent Trauma .

• Radiopharmaceutical development
• PET imaging
• Inflammatory diseases
• +5 more

Professor Anne Roivainen is a Professor of Preclinical Imaging and Drug Research at the Turku PET Centre, University of Turku and Turku University Hospital. Her research group focuses on developing novel radiopharmaceuticals for PET imaging of inflammatory diseases across multiple organ systems. Her primary research interests include: Development of radiopharmaceuticals for PET imaging Molecular imaging of inflammatory processes Vascular adhesion protein 1 (VAP-1) as a target for inflammation imaging Cardiovascular imaging techniques Applications in oncology, particularly glioblastoma Professor Roivainen's recent publications (2025) demonstrate a strong research output across multiple domains including cardiovascular imaging, inflammation, obesity, and cancer. Her work shows a consistent focus on translating preclinical imaging findings to potential clinical applications, particularly in developing more specific markers for inflammation imaging beyond the current standard of 18F-FDG. Professor Roivainen actively supervises graduate students, with at least one PhD candidate (Putri Andriana) scheduled to defend in July 2025. Her research group maintains strong connections between the University of Turku and Turku University Hospital, facilitating translational research from bench to bedside. Her laboratory (Roivainen Group) operates within the Turku PET Centre, which provides state-of-the-art facilities for preclinical and clinical imaging research. The group follows a comprehensive development pipeline for PET radiopharmaceuticals, from initial concept through preclinical validation to potential clinical application.

• Coronary artery disease
• PET imaging
• Inflammation
• +3 more

Mia Ståhle is a Research Fellow at the Turku PET Centre, University of Turku, specializing in cardiovascular PET imaging and translational research. Her primary affiliations include the Roivainen Group, where she investigates molecular targets for inflammation and coronary diseases using preclinical models. Research Focus: Her expertise spans: PET tracer development for folate receptors, GLP-1 receptors, and integrins Imaging of myocardial infarction mechanisms and atherosclerosis Multimodal image analysis tools (e.g., Carimas software) Translational approaches bridging animal models to clinical diagnostics Publication Trends (2020-2025): Recent work demonstrates a consistent focus on novel radiotracers for cardiovascular inflammation, autoradiography techniques, and molecular imaging of heart failure. Studies frequently involve rat/mouse models of disease and emphasize clinical applicability. Laboratory Affiliation: She conducts research within the Roivainen Group at Turku PET Centre, which specializes in developing targeted imaging probes for inflammatory and metabolic disorders.

• Nutritional Science
• Metabolic Health
• Gut Microbiome Research
• +5 more

Dr. Andreas Kolb is a Senior Research Fellow at the Rowett Institute, University of Aberdeen, within the School of Medicine, Medical Sciences and Nutrition. He has been in his current position since 2015, having previously served as a Research Fellow at the same institute from 2006-2015. His academic journey includes positions as Principal Investigator and Investigator at the Hannah Research Institute in Scotland, followed by postdoctoral and doctoral work at German universities. Dr. Kolb's educational background includes a PhD from the Institute of Molecular Animal Breeding at the University of Munich (1989-1992), followed by postdoctoral research at the Institute of Virology and Immunology, University of Würzburg (1992-1997). His primary research focuses on two interconnected areas: (1) the impact of secondary plant metabolites and toxins on metabolic health regulation through the gut microbiome and bile acid pathways, and (2) the influence of early life nutrition on adult metabolic health and aging processes. Dr. Kolb has developed cell-based assay systems to measure toxin concentrations in environmental and food samples, and his work explores how dietary components alter bile acid composition in the gut and serum. Analysis of Dr. Kolb's recent publications reveals a strong emphasis on molecular mechanisms of metabolic regulation, genetic engineering approaches, and the relationship between nutrition and health outcomes. His work spans nutritional science, molecular biology, and toxicology, with particular attention to mammary gland development, protein biosynthesis, and metabolic programming across the lifespan. As an educator, Dr. Kolb serves as Postgraduate Research Coordinator at the Rowett Institute and Chair of the PGR Liaison Committee for the School of Medicine, Medical Sciences and Nutrition. He teaches courses including ME2511 (Student Selected Components), SM2501 (Research Skills for Medical Sciences), SM2001 (Foundation Skills for Medical Sciences), and GN3502 (Genetics). He is an Associate Fellow of The Higher Education Academy. Dr. Kolb currently supervises four PhD students (Khulod Hasaballah, Amane Alaroud, Amanda Mathieson, and Brendan Kesler) and has previously mentored four PhD students to completion (Alina Zitskaja, Patrikas Pultinevicius, Jennifer Harbottle, and Christopher Knowles). His research group investigates dietary and environmental impacts on metabolic health, focusing on bile acid signaling mechanisms and early life nutrition effects on adult health outcomes.

• Molecular Biology
• Cellular Biology
• Developmental Biology
• +6 more

Sung-Eun Kim is a Research Assistant Professor in the Department of Molecular Biosciences within the College of Natural Sciences at The University of Texas at Austin. With a strong academic background from Yonsei University in South Korea where they earned their Bachelor's, Master's, and Ph.D. degrees, Dr. Kim has established a research career focused on developmental biology and cellular signaling pathways. Dr. Kim's educational journey began at Yonsei University where they completed a Bachelor of Science in 2002, followed by a Master of Science in 2004, and ultimately a Ph.D. in 2008. Their academic path then led them to Boston Children's Hospital/Harvard Medical School for postdoctoral training before joining the University of Texas system. Dr. Kim's research program centers on understanding the molecular mechanisms underlying neural tube defects (NTDs), with particular focus on how signaling pathways including Wnt, Sonic hedgehog (SHH), PCP, and folate one-carbon metabolism contribute to proper neural tube closure during embryonic development. Their laboratory employs a diverse array of techniques including cell culture, biochemical assays, molecular and cell biological approaches, and mouse genetics to investigate these critical developmental processes. A key aspect of their current work involves building expertise in mouse embryology to better model human neural tube defects. Analysis of Dr. Kim's publication record reveals a consistent research trajectory spanning developmental biology, cellular signaling, and disease mechanisms. Early work focused on Wnt and Ras-ERK signaling cross-regulation in colon cancer models, while more recent publications demonstrate a shift toward understanding the genetic basis of neural tube defects. Their research bridges basic molecular mechanisms with clinical applications, particularly in understanding how genetic variants contribute to developmental disorders. IUBMB 2018 travel grant award Postdoctoral Fellowship, National Research Foundation (NRF), South Korea (2009-2010) Dr. Kim's research program has been supported through various institutional mechanisms at UT Austin and previously through competitive fellowships. Their work on neural tube defects represents an important contribution to understanding the genetic and molecular basis of these common birth defects, with potential implications for prevention strategies. The laboratory maintains active collaborations with clinical researchers studying human neural tube defect cases. Dr. Kim's laboratory focuses on neural tube defect research using both mouse models and cellular systems. Their work integrates genetic, molecular, and developmental approaches to understand how signaling pathways coordinate during embryonic development. The lab has particular expertise in Wnt receptor complex regulation and its role in developmental processes.

Keith PecorView profile

Professor

• Freshwater Animal Ecology
• Animal Behavior
• Ecological Modeling
• +3 more

Keith Pecor is a Professor of Biology in the Department of Biology at The College of New Jersey (TCNJ), School of Science, specializing in freshwater animal ecology and interdisciplinary health research. His academic journey spans foundational ecological studies to contemporary investigations of mental health and neurodevelopmental disorders. Education: Ph.D. in Biology, University of Michigan, 2005 M.S. in Biology, University of Michigan, 2002 B.S. in Biology, University of Memphis, 2000 Pecor's research evolved from freshwater ecology and animal behavior to include mental health, ADHD, autism spectrum disorders, and pandemic impacts. His early work examined crayfish foraging trade-offs and phenological responses to climate change, while recent publications focus on academic stress, sleep health, and micronutrient effects in pediatric populations. This interdisciplinary shift demonstrates adaptability in addressing emerging public health concerns through collaborative medical research. Analysis of his 15 most recent publications (2016-2022) reveals three dominant themes: 40% address ADHD/autism and related interventions, 33% examine pandemic mental health impacts, and 27% cover ecological modeling and science education. His work frequently employs cross-cultural methodologies and clinical collaborations, with increasing emphasis on adolescent health outcomes. Scientific Awards: No specific awards documented in source material Pecor actively mentors undergraduate researchers through multiple independent study courses and first-year research programs. His teaching portfolio includes Ecology and Field Biology, Biology of Invertebrates, and research capstone courses, reflecting commitment to hands-on learning. While grant details are unspecified, his extensive co-authorship with medical researchers suggests involvement in funded interdisciplinary projects. As a Society for Freshwater Science member, he maintains connections to ecological research communities despite his expanded health-focused work.